![Byeong-Hui Jeon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 3 M $ as of 2026-06-29
Byeong-Hui Jeon is currently Co-Chief Executive Officer & Executive Director at CytoGen, Inc., starting in 2025.
Education includes a doctorate from Seoul National University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CYTOGEN, INC. 5.6% | 2026-06-25 | 1,295,271 ( 5.6% ) | 3 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| CYTOGEN, INC. | Chief Executive Officer | 2025-01-01 |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoGen, Inc.
 CytoGen, Inc. BiotechnologyHealth Technology Engages in research and development in liquid biopsy application for cancer treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
